November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...

New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption ...

Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ...

Profound would also like to congratulate Satoru Takahashi, MD, PhD, of Takatsuki General Hospital in Japan, for receiving a Certificate of Merit award from RSNA for his presentation titled “TULSA for ...

Mitochondrial disease refers to a group of conditions that affect how mitochondria work. While there is no cure for mitochondrial disease, supportive care can help prevent life threatening ...

If you are a middle child, or have a sibling who is a middle child, you may be wondering if “middle child syndrome” is a real thing. Middle child syndrome is the belief that middle children are ...